![Patrick Enright](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrick Enright
Direktör/Styrelseledamot på
VERA THERAPEUTICS, INC.
Förmögenhet: 90 M $ per 2026-08-31
Profil
Mr. Patrick G.
Enright is an Independent Director at Veradermics, Inc., an Independent Director at BioAge Labs, Inc., an Independent Director at Zenas BioPharma, Inc., an Independent Director at Vera Therapeutics, Inc., a Chairman at CuraSen Therapeutics, Inc., an Independent Director at Jazz Pharmaceuticals Plc and a Managing Director at Longitude Capital Management Co LLC.
He is on the Board of Directors at Veradermics, Inc., BioAge Labs, Inc., Zenas BioPharma, Inc., Opna Immuno-Oncology SA, Endeavor BioMedicines, Inc, Vera Therapeutics, Inc., Epirium Bio, Inc., Orbus Therapeutics, Inc., Lemo USA, Inc., Jazz Pharmaceuticals Plc, InfaCare Pharmaceutical Corp.
and Raven Biotechnologies, Inc. Mr. Enright was previously employed as an Independent Director by SutroVax, Inc., an Independent Director by Esperion Therapeutics, Inc., an Independent Director by CardioDx, Inc., an Independent Director by Corcept Therapeutics, Inc., a Managing Director by Pequot Ventures, a Managing Director by Pequot Capital Corp., a Senior VP-Finance & Business Development by Boehringer Mannheim Pharmaceuticals Corp., a Managing Member by Delta Opportunity Fund LLC, a Vice President by PaineWebber Development Corp., a Principal by Geneva Pharmaceuticals, Inc., a Chief Financial Officer & SVP-Business Development by Valentis, Inc., and a Chief Financial Officer & Senior Vice President by Urigen Pharmaceuticals, Inc. He also served on the board at Dascena, Inc., National Venture Capital Association, Rivus Pharmaceuticals, Inc., Aptinyx, Inc., Aimmune Therapeutics, Inc., Jazz Pharmaceuticals, Inc., Sequenom, Inc., Threshold Pharmaceuticals, Inc., Codexis, Inc., Horizon Therapeutics Ltd. (Ireland), MAP Pharmaceuticals, Inc., DiObex, Inc., Horizon Therapeutics, Inc., Prestwick Pharmaceuticals, Inc., Tecan Genomics, Inc. and Xanodyne Pharmaceuticals, Inc. He received his undergraduate degree from Stanford University and an MBA from The Wharton School of the University of Pennsylvania.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
4,02 % | 2026-06-15 | 2 619 189 ( 4,02 % ) | 85 M $ | 2026-08-31 |
| 2026-08-31 | 21 278 ( 0,03 % ) | 5 M $ | 2026-08-31 | |
| 2026-05-21 | 5 882 ( 0,01 % ) | 200 459 $ | 2026-08-31 | |
BIOAGE LABS, INC. -.--% | 2026-06-10 | 0 ( -.--% ) | - $ | 2026-08-31 |
Aktiva positioner av Patrick Enright
| Företag | Position | Start |
|---|---|---|
| VERA THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2020-11-01 |
| JAZZ PHARMACEUTICALS PLC | Direktör/Styrelseledamot | 2009-07-01 |
| BIOAGE LABS, INC. | Direktör/Styrelseledamot | 2024-02-01 |
| VERADERMICS, INCORPORATED | Direktör/Styrelseledamot | 2024-12-01 |
Epirium Bio, Inc.
 Epirium Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems | Direktör/Styrelseledamot | 2019-06-01 |
Lemo USA, Inc.
 Lemo USA, Inc. Electronic ComponentsElectronic Technology Designs and manufactures custom connectors | Direktör/Styrelseledamot | 2012-01-01 |
Endeavor BioMedicines, Inc
 Endeavor BioMedicines, Inc Miscellaneous Commercial ServicesCommercial Services Operates clinical-stage company that develops hedgehog inhibitor for Idiopathic pulmonary fibrosis | Direktör/Styrelseledamot | 2020-12-01 |
Opna Immuno-Oncology SA
 Opna Immuno-Oncology SA BiotechnologyHealth Technology Engages in research and development of biotechnology products | Direktör/Styrelseledamot | 2022-06-01 |
Raven Biotechnologies, Inc.
 Raven Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops antibody therapeutics | Direktör/Styrelseledamot | - |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░ | ░░░░░░░░░░ |
Tidigare kända positioner av Patrick Enright
| Företag | Position | Slut |
|---|---|---|
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Patrick Enrights utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
74
Första gradens relationer
43
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 43 |
|---|---|
Valentis, Inc.
 Valentis, Inc. Pharmaceuticals: MajorHealth Technology Develops products for urology indications | Health Technology |
Sequenom, Inc.
 Sequenom, Inc. Medical/Nursing ServicesHealth Services Provides genomic and genetic analysis solutions | Health Services |
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
Corcept Therapeutics, Inc.
 Corcept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of drugs which treat severe metabolic, oncologic and neuropsychiatric disorders | Health Technology |
Threshold Pharmaceuticals, Inc.
 Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
DiObex, Inc.
 DiObex, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for metabolic disease treatment | Health Technology |
Tecan Genomics, Inc.
 Tecan Genomics, Inc. Electronic Equipment/InstrumentsElectronic Technology Provides genomics sample preparation solutions | Electronic Technology |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes generic pharmaceutical products | Health Technology |
Codexis, Inc.
 Codexis, Inc. Chemicals: SpecialtyProcess Industries Develops biocatalytic chemical processes | Process Industries |
MAP Pharmaceuticals LLC
 MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology Develops therapies and inhalation delivery technologies | Health Technology |
CardioDx, Inc.
 CardioDx, Inc. Medical/Nursing ServicesHealth Services Operates as a cardiovascular genomic diagnostics company | Health Services |
Raven Biotechnologies, Inc.
Raven Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops antibody therapeutics | Commercial Services |
Prestwick Pharmaceuticals, Inc.
 Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for diseases related to the central nervous system | Health Technology |
InfaCare Pharmaceutical Corp.
 InfaCare Pharmaceutical Corp. BiotechnologyHealth Technology Develops and commercializes proprietary pharmaceuticals for the neonatal and pediatric patient population | Health Technology |
Epirium Bio, Inc.
Epirium Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems | Health Technology |
Horizon Therapeutics Ltd. (Ireland)
 Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Discovers, develops and manufactures pharmaceuticals for autoimmune & inflammatory diseases | Health Technology |
Delta Opportunity Fund LLC | |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FirstMark Capital LLC
 FirstMark Capital LLC Investment ManagersFinance FirstMark Capital invests in startup companies located in the United States, Canada and Europe primarily in New York and broader East Coast ecosystem. The firm focuses in consumer, enterprise and frontier technology sectors. It provides financing for early stage capital requirements. It acts as a lead investor. It also takes a seat on the board of directors. | Finance |
Xanodyne Pharmaceuticals, Inc.
 Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
National Venture Capital Association
 National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services Provides business association services | Commercial Services |
Horizon Therapeutics, Inc.
 Horizon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops prescription drugs for mild to moderate pain relief | Health Technology |
Vaneltix Pharma, Inc.
 Vaneltix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for patients with urological ailments | Health Technology |
Boehringer Mannheim Pharmaceuticals Corp. | |
Longitude Capital Management Co LLC
 Longitude Capital Management Co LLC Investment ManagersFinance Longitude Capital invests in both private and public companies located in the United States. The firm targets companies operating in the fields of medical technology, biotechnology and health solutions. It participates in early stage capital requirements. | Finance |
PaineWebber Development Corp. | |
Lemo USA, Inc.
Lemo USA, Inc. Electronic ComponentsElectronic Technology Designs and manufactures custom connectors | Electronic Technology |
Jazz Pharmaceuticals Plc
 Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of desensitization treatments for peanut and food allergies | Health Technology |
Vaxcyte, Inc.
 Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
Orbus Therapeutics, Inc.
 Orbus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures products to treat brain cancer & rare diseases | Health Technology |
Aptinyx, Inc.
 Aptinyx, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies to treat disorders of the brain and nervous system | Health Technology |
BioAge Labs, Inc.
 BioAge Labs, Inc. BiotechnologyHealth Technology Develops therapies obesity for metabolic diseases | Health Technology |
CuraSen Therapeutics, Inc.
 CuraSen Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops novel treatments for psychiatric and neurodegenerative diseases | Health Technology |
Rivus Pharmaceuticals, Inc.
 Rivus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Dascena, Inc.
 Dascena, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical testing services | Commercial Services |
Pequot Capital Corp.
 Pequot Capital Corp. Investment ManagersFinance Provides investment advisory services | Finance |
Vera Therapeutics, Inc.
 Vera Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which focuses on development and treatments for immunological & inflammatory diseases | Health Technology |
Veradermics, Inc.
 Veradermics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company for treatment of dermatology and aesthetics problems | Health Technology |
Endeavor BioMedicines, Inc
Endeavor BioMedicines, Inc Miscellaneous Commercial ServicesCommercial Services Operates clinical-stage company that develops hedgehog inhibitor for Idiopathic pulmonary fibrosis | Commercial Services |
Opna Immuno-Oncology SA
Opna Immuno-Oncology SA BiotechnologyHealth Technology Engages in research and development of biotechnology products | Health Technology |
